Spiking fevers with clozapine treatment

Clinical Neuropharmacology

Volumn 20, Issue 2, 1997, Pages 168-170

  Trémeau, Fabien ^a   Clark, Scott C ^a,b   Printz, David ^a   Kegeles, Lawrence S ^a   Malaspina, Dolores ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NYSP1 Box 2 ^*  (United States)

Author keywords

Clozapine; Dopamine; Neutrophilia; Side effect; Spiking fever

Indexed keywords

CLOZAPINE; DOPAMINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CASE REPORT; DIGESTIVE SYSTEM FUNCTION DISORDER; DOPAMINE RELEASE; FEMALE; FEVER; HUMAN; HYPERTHERMIA; MALE; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPHILIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THERMOREGULATION;

EID: 0343580494     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199704000-00009     Document Type: Article

References (15)

1. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 1991;17:247-61.
2. Astagneau F, Gottot S, Gobin Y, et al. Nosocomial outbreak of Enterobacter agglomerans pseudobacteraemia associated with nonsterile blood collection tubes. J Hosp Infect 1994;27:73-9.
3. Clark WG, Lipton JM. Changes in body temperature alter administration of ammo acids, peptides, dopamine, neuroleptics and related agents. II. Neurosci Biobehav Res 1985;9:199-271.
4. Patterson BD, Jennings JL. Spiking fever and profuse diarrhea with clozapine treatment [Letter]. Am J Psychiatry 1993;150(7):1126.
5. Druss BG, Mazure CM. Transient fever and hematologic abnormalities during clozapine use [Letter]. J Clin Psychopharmacol 1993;13(2):155-6.
6. Descottes J. Immunology of drugs and chemicals, 2nd ed. Amsterdam: Elsevier. 1988.
7. Maes M, Meltzer HY, Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994;89:346-51.
8. Pollmäacher T, Hinze-Selch D, Mullington J, Holsboer F. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors [Letter]. Arch Gen Psychiatry 1995;52:877-8.
9. Costentin J, Duterte-Boucher D, Panissaud C, Michael-Titus A. Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice. Neuropharmacology 1990;29:31-5.
10. Subramaniam S, Lucki I, McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res 1992;571:313-22.
11. Verma A, Kulkarni SK. Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats. Arch Int Pharmacodyn Ther 1993;324:17-32.
12. Farde L. Nordströom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 1992;49:538-44.
13. Hess EJ, Norman AB, Creese I. Chrome treatment with dopamine receptor antagonists: behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J Neurosci 1988;8(7):2361-70.
14. Coward DM, Imperato A, Urwyler S, White TG. Biochemical and behavioural properties of clozapine. Psychopharmacology 1989;99:S6-12.
15. Salmi P, Karlsson T, Ahlenius S. Antagonist by SCH 23390 of clozapine-induced hypothermia in the rat. Eur J Pharmacol 1994;253:67-73.